Skip to content
    Boston Millennia Partners logo

    Boston Millennia Partners

    Boston, Massachusetts, United StatesFounded 1997

    Boston Millennia Partners is a venture capital and growth equity firm providing financing to high-growth companies in the healthcare and life sciences industries. The firm employs a thematic, buy-and-build strategy with active participation in its portfolio companies.

    46% of their portfolio is in Healthcare. Average disclosed round size is $26.1M (across 24 rounds with reported amounts).

    Find people at Boston Millennia Partners on Goldilocks AI

    Portfolio

    17

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    DC

    Dana Callow

    Managing Partner

    MH

    Marty Hernon

    General Partner

    RR

    Ren Roome

    Partner

    AM

    Amy Merk

    Director of Administration and Investor Relations

    EC

    Elizabeth Callow

    Senior Associate

    BT

    Bruce Tiedemann

    Chief Financial Officer

    CH

    Clodagh Hoey

    Finance Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    24 investments
    CompanyRoundAmountDate
    Quant Health logoQuant HealthSeed$2.6MOct 2022
    Atropos Health logoAtropos HealthSeries A$14MAug 2022
    AAtroposSeries A$14MAug 2022
    SomaLogic logoSomaLogicSeries A$214MDec 2020
    CCOTASeries C$34MNov 2020
    CCOTA HealthcareSeries D$34MNov 2020
    SomaLogic logoSomaLogicSeries A$121MJan 2020
    FForefront TelecareSeries A$15MApr 2019
    CCOTASeries C$40MFeb 2018
    BBivarusSeries B$4MMar 2017
    BBivarusSeries B$4MMar 2016
    FForefront TelecareUnknown$660KJan 2011
    FForefront TelecareUnknown$310KJan 2010
    CCombinatorxUnknown$30MMar 2004
    Cecelia Health logoCecelia HealthSeries B$13M—
    BEKHealth logoBEKHealthGrowth$4M—
    CC2SenseSeed$3.2M—
    HHistogenics CorporationSeries A$13.1M—
    CCOTASeries B$18M—
    CCOTASeries A$7M—
    CRIO logoCRIOSeries A$3.5M—
    Collegium Pharma logoCollegium PharmaSeries B$22.5M—
    Odyssey Logistics & Technology logoOdyssey Logistics & TechnologyUnknown$500K—
    NNexidiaUnknown$13M—

    Top Co-Investors

    Last updated: 20 October 2026